Back
Leggett & Platt Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
29
LEG
Leggett & Platt
Last Price:
12.13
Seasonality Move:
5.87%
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
67.07
Seasonality Move:
13.3%
Sell
29
Leggett & Platt (LEG)
is a Sell
Is Leggett & Platt a Buy, Sell or Hold?
- The current Leggett & Platt [LEG] share price is $12.13. The Score for LEG is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- LEG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $67.07. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LEG Stock Price Chart
What is Leggett & Platt's stock price today?
-
The Leggett & Platt share price today is $12.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEG is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $67.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
LEG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 42.34 | Sell |
| Chaikin Money Flow: | 628951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.13 - 13.11) | Sell |
| Bollinger Bands (100): | (11.73 - 13.19) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.77 | Sell |
| Relative Strength Index (14 RSI): | 36.99 | Sell |
| Chaikin Money Flow: | 38184 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.11 - 70.53) | Sell |
| Bollinger Bands (100): | (70.87 - 88.17) | Sell |
LEG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.17 | Sell |
| 20-day SMA: | 12.51 | Sell |
| 50-day SMA: | 12.71 | Sell |
| 200-day SMA: | 14.88 | Sell |
| 8-day EMA: | 12.23 | Sell |
| 20-day EMA: | 12.44 | Sell |
| 50-day EMA: | 12.63 | Sell |
| 200-day EMA: | 15.4 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.42 | Buy |
| 20-day SMA: | 68.68 | Sell |
| 50-day SMA: | 73.15 | Sell |
| 200-day SMA: | 82.32 | Sell |
| 8-day EMA: | 67.03 | Buy |
| 20-day EMA: | 68.41 | Sell |
| 50-day EMA: | 72.52 | Sell |
| 200-day EMA: | 80.98 | Sell |
Leggett & Platt Earnings Growth & LEG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.14 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Leggett & Platt Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||